Iranian Journal of Pediatrics

Published by: Kowsar

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma

Hikmet Gulsah Tanyildiz 1 , * , Inci Yildiz 1 , Nuray Bassullu 2 , Nukhet Tuzuner 2 , Alp Ozkan 1 , Tiraje Celkan 1 and Hilmi Apak 1
Authors Information
1 Department of Pediatric Hematology/Oncology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
2 Department of Pathology, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
Article information
  • Iranian Journal of Pediatrics: December 28, 2015, 25 (6); e2359
  • Published Online: December 23, 2015
  • Article Type: Research Article
  • Received: May 21, 2015
  • Revised: September 7, 2015
  • Accepted: September 20, 2015
  • DOI: 10.5812/ijp.2359

To Cite: Tanyildiz H G, Yildiz I, Bassullu N, Tuzuner N, Ozkan A, et al. The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma, Iran J Pediatr. 2015 ; 25(6):e2359. doi: 10.5812/ijp.2359.

Abstract
Copyright © 2015, Growth & Development Research Center.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med. 1998; 339(21): 1506-14[DOI][PubMed]
  • 2. Morente MM, Piris MA, Abraira V, Acevedo A, Aguilera B, Bellas C, et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood. 1997; 90(6): 2429-36[PubMed]
  • 3. Naresh KN, Johnson J, Srinivas V, Soman CS, Saikia T, Advani SH, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol. 2000; 11(1): 91-6[DOI]
  • 4. Enblad G, Sandvej K, Sundstrom C, Pallesen G, Glimelius B. Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population. Acta Oncol. 1999; 38(4): 425-9[PubMed]
  • 5. Vestlev PM, Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Bendtzen SM. Prognosis of Hodgkin's disease is not influenced by Epstein-Barr virus latent membrane protein. Int J Cancer. 1992; 50(4): 670-1[PubMed]
  • 6. Enblad G, Sandvej K, Lennette E, Sundström C, Klein G, Glimelius B, et al. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed‐Sternberg cells of patients with Hodgkin's disease. In J Cancer. 1997; 72(3): 394-7[DOI]
  • 7. Axdorph U, Porwit-MacDonald A, Sjoberg J, Grimfors G, Ekman M, Wang W, et al. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer. 1999; 81(7): 1182-7[DOI][PubMed]
  • 8. Vassallo J, Metze K, Traina F, de Souza CA, Lorand-Metze I. Expression of Epstein-Barr virus in classical Hodgkin's lymphomas in Brazilian adult patients. Haematologica. 2001; 86(11): 1227-8[PubMed]
  • 9. De Matteo E, Baron AV, Chabay P, Porta J, Dragosky M, Preciado MV. Comparison of Epstein-Barr virus presence in Hodgkin lymphoma in pediatric versus adult Argentine patients. Arch Pathol Lab Med. 2003; 127(10): 1325-9[DOI][PubMed]
  • 10. Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, et al. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Mod Pathol. 2003; 16(6): 566-73[DOI][PubMed]
  • 11. Glavina-Durdov M, Jakic-Razumovic J, Capkun V, Murray P. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease. Br J Cancer. 2001; 84(9): 1227-34[DOI][PubMed]
  • 12. Glaser SL, Lin RJ, Stewart SL, Ambinder RF, Jarrett RF, Brousset P, et al. Epstein‐Barr virus‐associated Hodgkin's disease: Epidemiologic characteristics in international data. Int J Cancer. 1997; 70(4): 375-82[DOI]
  • 13. Lee JH, Kim Y, Choi JW, Kim YS. Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis. Arch Med Res. 2014; 45(5): 417-31[DOI][PubMed]
  • 14. Ping LY, Ding N, Shi YF, Sun L, Zheng W, Xie Y, et al. [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014; 22(1): 78-84[DOI][PubMed]
  • 15. Herling M, Rassidakis GZ, Medeiros LJ, Vassilakopoulos TP, Kliche KO, Nadali G, et al. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome. Clin Cancer Res. 2003; 9(6): 2114-20[PubMed]
  • 16. Spector N, Milito CB, Biasoli I, Luiz RR, Pulcheri W, Morais JC. The prognostic value of the expression of Bcl-2, p53 and LMP-1 in patients with Hodgkin's lymphoma. Leuk Lymphoma. 2005; 46(9): 1301-6[DOI][PubMed]
  • 17. Claviez A, Tiemann M, Luders H, Krams M, Parwaresch R, Schellong G, et al. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma. J Clin Oncol. 2005; 23(18): 4048-56[DOI][PubMed]
  • 18. Koh YW, Yoon DH, Suh C, Huh J. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea. Ann Hematol. 2012; 91(9): 1403-12[DOI][PubMed]
  • 19. Kwon JM, Park YH, Kang JH, Kim K, Ko YH, Ryoo BY, et al. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma. Ann Hematol. 2006; 85(7): 463-8[DOI][PubMed]
  • 20. Keegan TH, Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, et al. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study. J Clin Oncol. 2005; 23(30): 7604-13[DOI][PubMed]
  • 21. Engel M, Essop MF, Close P, Hartley P, Pallesen G, Sinclair-Smith C. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases. J Clin Pathol. 2000; 53(3): 182-6[PubMed]
  • 22. Mao Y, Lu MP, Lin H, Zhang da W, Liu Y, Li QD, et al. Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studies. PLoS One. 2013; 8(4)[DOI][PubMed]
  • 23. Ishtiaq S, Hassan U, Mushtaq S, Akhtar N. Determination of frequency of epstein-barr virus in non- Hodgkin lymphomas Using EBV latent membrane protein 1 (EBV-LMP1) immunohistochemical staining. Asian Pac J Cancer Prev. 2013; 14(6): 3963-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments